Enhanced liver uptake of opsonized red blood cells after in vivo transfer of FcγRIIA cDNA to the liver

Blood

Volumn 94, Issue 10, 1999, Pages 3448-3455

  Bezdicek, Petr ^b   Worgall, Stefan ^b   Kovesdi, Imre ^b   Kim, Moo Kyung ^b   Park, Jong Gu ^b   Vincent, Theresa ^b   Leopold, Philip L ^b   Schreiber, Alan D ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; COMPLEMENTARY DNA; FC RECEPTOR; IMMUNOGLOBULIN G; MESSENGER RNA;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE TRANSFER; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; NONHUMAN; NORTHERN BLOTTING; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0033571292     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.10.3448.422k02_3448_3455     Document Type: Article

References (36)

1. Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol 9:457, 1991
2. Sandor M, Lynch RG: The biology and pathology of Fc receptors. J Clin Immunol 13:237, 1993
3. de Haas M, Vossebeld PJ, von dem Borne AE, Roos D: Fc γ receptors of phagocytes. J Lab Clin Med 126:330, 1995
4. McKenzie SE, Schreiber AD: Fcγ receptors in phagocytes. Curr Opin Hematol 5:16, 1998
5. Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH: Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300:518, 1979
6. Ruiz P, Gomez F, Schreiber AD: Impaired function of macrophage Fc γ receptors in end-stage renal disease. N Engl J Med 322:717, 1990
7. Gomez F, Ruiz P, Schreiber AD: Impaired function of macrophage Fc γ receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 331:1122, 1994
8. Gandossini M, Souhami RL, Babbage J, Addison IE, Johnson AL, Berenbaum MC: Neutrophil function during chemotherapy for Hodgkin's disease. Br J Cancer 44:863, 1981
9. Pruzanski W, Saito S, De Boer G: Modulatory activity of chemotherapeutic agents on phagocytosis and intracellular bactericidal activity of human polymorphonuclear and mononuclear phagocytes. Cancer Res 43:1420, 1983
10. Schreiber AD, Nettl FM, Sanders MC, King M, Szabolcs P, Friedman D, Gomez F: Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells. J Immunol 141:2959, 1988
11. Yamada Y, Hara I, Gohji K, Okada H, Arakawa S, Kamidono S: Recovery of leukocyte function after super-high-dose chemotherapy with peripheral blood stem cell transplantation in testicular cancer patients. Int J Cancer 72:39, 1997
12. Hosea SW, Brown EJ, Hamburger MI, Frank MM: Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304:245, 1981
13. Cornacoff JB, Hebert LA, Smead WL, Van Aman ME, Birmingham DJ, Waxman FJ: Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 71:236, 1983
14. Hebert LA: The clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 17:352, 1991
15. Hunter S, Kamoun M, Schreiber AD: Transfection of an Fcγ receptor cDNA induces T cells to become phagocytic. Proc Natl Acad Sci USA 91:10232, 1994
16. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Paakko PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, Jallat S, Pavirani A, Lecocq J-P, Crystal RG: Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431, 1991
17. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, Pavirani A, Lecocq J-P, Crystal RG: In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143, 1992
18. Indik Z, Kelly C, Chien P, Levinson AI, Schreiber AD: Human Fc-γRII, in the absence of other Fc γ receptors, mediates a phagocytic signal. J Clin Invest 88:1766, 1991
19. Hersh J, Crystal RG, Bewig B: Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther 2:124, 1995
20. Graham FL, Prevec L: Manipulation of adenovirus vectors, in Murray EJ (ed): Methods in Molecular Biology. Clifton, NJ, Humana, 1991, p 109
21. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8:42, 1994
22. Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG: Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH. Nat Genet 12:274, 1996
23. Falk LA: Measurement of Fc γ receptor-mediated binding and phagocytosis, in Coligan JE, Kruisbeek AM, Shevach EM, Strober W (eds): Current Protocols in Immunology. New York, NY, Wiley, 1995, p 14.8.1
24. Herz J, Gerard RD: Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol in normal mice. Proc Natl Acad Sci USA 90:2812, 1993
25. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG: Innate immune mechanisms dominate elimination of adenovirus vectors following in vivo administration. Hum Gene Ther 8:37, 1997
26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
27. Ruiz P, Gomez F, King M, Lopez R, Darby C, Schreiber AD: In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc γ receptors. J Clin Invest 88:149, 1991
28. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ: Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 172:19, 1990
29. Rascu A, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG: Clinical relevance of Fc γ receptor polymorphisms. Ann NY Acad Sci 815:282, 1997
30. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA: Fcγ receptor IIA (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848, 1994
31. Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJ, Zegers BJ: Fey receptor IIA (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854, 1994
32. Tuijnman WB, Capel PJ, van de Winkel JG: Human low-affinity igg receptor FcγRIIA (CD32) introduced into mouse fibroblasts mediates phagocytosis of sensitized erythrocytes. Blood 79:1651, 1992
33. Indik ZK, Pan XQ, Huang MM, McKenzie SE, Levinson AI, Schreiber AD: Insertion of cytoplasmic tyrosine sequences into the nonphagocytic receptor FcγRIIB establishes phagocytic function. Blood 83:2072, 1994
34. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP: FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97:1348, 1996
35. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγRIIA. J lmmunol 153:1271, 1994
36. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ: Effect of tumor necrosis factor-induced integrin activation on Fcγ receptor II-mediated signal transduction: Relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189, 1995